Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

Completed · Not applicable

Conditions studied: Opiate Dependence

In brief

A randomized clinical trial evaluating whether Behavioral Drug and HIV Risk Reduction Counseling (BDRC), abstinence-contingent take-home buprenorphine (ACB), or the combination of the two improve efficacy and cost-effectiveness of standard buprenorphine treatment for opiate-dependent individuals in Malaysia.

Key facts

Study ID

NCT00539123

Run by

Yale University

People needed

234

Starts

2007-09-01

Expected to finish

2012-08-01

Last updated by the study team

2021-06-18

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• opioid dependence

You may not qualify if…

• current dependence on alcohol, benzodiazepines or sedatives current suicide or homicide risk current psychotic disorder or major depression inability to understand protocol or assessment questions life threatening or unstable medical problems more than 3x normal liver enzymes

Where it is running

• Yale University School of Medicine — New Haven, Connecticut, United States
• Substance Abuse Research Center — Muar town, Johor, Malaysia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.